Creso Pharma ltd
CPH.AX | CPH.AX
Creso was created to bring pharmaceutical expertise and methodological rigour to the world of cannabis and deliver quality products to people and animals everywhere. Founded by a team of highly-experienced pharmaceutical executives, Creso set out to leverage cutting edge science and research to develop, register, and commercialize innovative cannabis and hemp derived products.
Related content
The HighBrid Lab blends complementary therapies amid rising investor interest
Creso Pharma is joining forces with long-established psychedelics business Red Light Holland Corp.
Why Creso Pharma is Set to Be First-Mover in New Corner of Projected $16 Trillion Market
Creso Pharma's revolutionary approach to treating the $16 trillion mental health problem.
This firm is taking a diversified approach to two novel sectors helping millions worldwide...
Creso Pharma are entering a brand-new booming market as it rides the second green wave.
Billionaire John Hancock invests in Creso Pharma as share placing demand soars
Creso Pharma's latest share placing exceeded expectations with an upsized placement to $18m. Major investors include Australian Billionaire John...
Agreement to acquire established Canadian psychedelics company Halucenex Life Sciences Inc.
Creso Pharma has signed an agreement to acquire Halucenex Life Sciences, an established psychedelics company focused on developing treatments...
LOI Secured With ImpACTIVE To Drive Growth In North America And Europe
Creso signs non-binding LOI to conditionally enter US market with established partner
Creso Pharma is pleased to advise that it has executed a non-binding letter of intent (“LOI”) with leading CBD and plant-based remedies provider...